Sources | Names Used |
---|---|
CCLE, GRAY | PF-2341066 |
GDSC1000, FIMM | Crizotinib |
gCSI, CTRPv2 | crizotinib |
PharmacoGx | Crizotinib |
Database | Identifier |
---|---|
Smiles: | CC(C1=C(C=C(C=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Inchikey: | SCJHEFQWKWHQTO-GFCCVEGCSA-N |
Pubchem: | 54613769 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM46C | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
mRNA | AP1B1 | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
mRNA | ANKMY2 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | TMEM133 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
mRNA | FAM46C | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
mRNA | SPATA9 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
mRNA | SNX22 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
mRNA | SUPT7L | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | MTNR1A | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
mRNA | SIGLEC8 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |